PHARMACYCLICS INC 4
4 · PHARMACYCLICS INC · Filed May 28, 2015
Insider Transaction Report
Form 4
Smith David Duane
Director
Transactions
- Disposition from Tender
Common Stock
2015-05-26$261.25/sh−3,000$783,750→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−18,145→ 0 totalExercise: $1.24Exp: 2019-04-01→ Common Stock (18,145 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−11,597→ 0 totalExercise: $1.94Exp: 2019-10-01→ Common Stock (11,597 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−2,500→ 0 totalExercise: $1.92Exp: 2008-10-09→ Common Stock (2,500 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−55,555→ 0 totalExercise: $0.81Exp: 2019-01-02→ Common Stock (55,555 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2015-05-26−18,320→ 0 totalExercise: $1.31Exp: 2019-07-01→ Common Stock (18,320 underlying)
Footnotes (2)
- [F1]Price reflects aggregate per share consideration paid pursuant to the Tender Offer.
- [F2]Pursuant to terms of the Agreement and Plan of Reorganization (the "Merger Agreement") dated March 4, 2015, by and between the Issuer, AbbVie Inc., a Delaware corporation ("AbbVie"), Oxford Amherst Corporation, a Delaware corporation and a direct wholly owned subsidiary of AbbVie and Oxford Amherst LLC, a Delaware limited liability company and a direct wholly owned subsidiary of AbbVie this option was cancelled in exchange for a cash payment equal to the number of shares subject to the option multiplied by the difference between $261.25 and the exercise price of the option, subject to applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.